FDA investigates Diabetes Drug Metformin

The U.S. Food and Drug Administration is testing the popular Type-2 Diabetes medication, Metformin for a cancer-causing chemical has contaminated the drug.

The carcinogen N-Nitrosodimethylamine (NDMA). The FDA says the levels of NDMA in these medications are within the range of what naturally occurs in some foods and water.

“While we are aware that some regulatory agencies outside the U.S. may be recalling some metformin drugs, there are no metformin recalls affecting the U.S. market at this time,”

Dr. Janet Woodcock said in a statement released by the administration.

“The FDA is investigating whether metformin in the U.S. market contains NDMA, and whether it is above the acceptable daily intake limit of 96 nanograms.”

If you have questions about the investigation, you can call the FDA at 888-INFO-FDA.